161 related articles for article (PubMed ID: 24224478)
21. Histological spectrum of ependymomas and correlation of p53 and Ki-67 expression with ependymoma grade and subtype.
Suri VS; Tatke M; Singh D; Sharma A
Indian J Cancer; 2004; 41(2):66-71. PubMed ID: 15318011
[TBL] [Abstract][Full Text] [Related]
22. Peroxiredoxins and their expression in ependymomas.
Haapasalo T; Nordfors K; Järvelä S; Kok E; Sallinen P; Kinnula VL; Haapasalo HK; Soini Y
J Clin Pathol; 2013 Jan; 66(1):12-7. PubMed ID: 23076395
[TBL] [Abstract][Full Text] [Related]
23. [Analysis of microvascular density and the expression of vascular-endothelial growth factor (VEGF) and its membrane receptor Flk-1 in neuroblastoma].
Drozyńska E; Izycka-Swieszewska E; Balcerska A; Bodalski J; Bohosiewicz J; Brozyna A; Bubała H; Chybicka A; Grajkowska W; Koltan S; Madziara W; Rybczyńska A; Słociak M; Sońta-Jakimczyk D; Stolarska M; Perek D; Wachowiak J; Wysocki M
Med Wieku Rozwoj; 2006; 10(3 Pt 1):745-55. PubMed ID: 17317905
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis.
Bonnesen B; Pappot H; Holmstav J; Skov BG
Lung Cancer; 2009 Dec; 66(3):314-8. PubMed ID: 19324448
[TBL] [Abstract][Full Text] [Related]
25. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
26. Histomorphological spectrum and immunohistochemical characterization of hemangioblastomas: an entity of unclear histogenesis.
Epari S; Bhatkar R; Moyaidi A; Shetty P; Gupta T; Kane S; Jalali R
Indian J Pathol Microbiol; 2014; 57(4):542-8. PubMed ID: 25308004
[TBL] [Abstract][Full Text] [Related]
27. Phyllodes tumours of the breast: the role of CD34, vascular endothelial growth factor and β-catenin in histological grading and clinical outcome.
Ho SK; Thike AA; Cheok PY; Tse GM; Tan PH
Histopathology; 2013 Sep; 63(3):393-406. PubMed ID: 23772632
[TBL] [Abstract][Full Text] [Related]
28. Histopathological vascular investigation of the peritumoral brain zone of glioblastomas.
Tamura R; Ohara K; Sasaki H; Morimoto Y; Yoshida K; Toda M
J Neurooncol; 2018 Jan; 136(2):233-241. PubMed ID: 29188530
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical expression of cycloxygenase-2 in astrocytoma: correlation with angiogenesis, tumor progression and survival.
El-Sayed M; Taha MM
Turk Neurosurg; 2011 Jan; 21(1):27-35. PubMed ID: 21294088
[TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor (VEGF) expression and microvascular density in salivary gland tumours.
Faur AC; Lazar E; Cornianu M
APMIS; 2014 May; 122(5):418-26. PubMed ID: 23937241
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
[TBL] [Abstract][Full Text] [Related]
32. Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2.
Farschtschi S; Merker VL; Wolf D; Schuhmann M; Blakeley J; Plotkin SR; Hagel C; Mautner VF
Acta Neurol Scand; 2016 Jun; 133(6):475-80. PubMed ID: 26369495
[TBL] [Abstract][Full Text] [Related]
33. Pathology of spinal ependymomas: an institutional experience over 25 years in 134 patients.
Tarapore PE; Modera P; Naujokas A; Oh MC; Amin B; Tihan T; Parsa AT; Ames CP; Chou D; Mummaneni PV; Weinstein PR
Neurosurgery; 2013 Aug; 73(2):247-55; discussion 255. PubMed ID: 23670032
[TBL] [Abstract][Full Text] [Related]
34. The prognostic significance of angiogenesis and the effect of vascular endothelial growth factor on angiogenic process in Wilms' tumour.
Ozluk Y; Kilicaslan I; Gulluoglu MG; Ayan I; Uysal V
Pathology; 2006 Oct; 38(5):408-14. PubMed ID: 17008278
[TBL] [Abstract][Full Text] [Related]
35. Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.
Kurt E; Zheng PP; Hop WC; van der Weiden M; Bol M; van den Bent MJ; Avezaat CJ; Kros JM
Cancer; 2006 Jan; 106(2):388-95. PubMed ID: 16342252
[TBL] [Abstract][Full Text] [Related]
36. Nucleolin overexpression is associated with an unfavorable outcome for ependymoma: a multifactorial analysis of 176 patients.
Chen C; Chen L; Yao Y; Qin Z; Chen H
J Neurooncol; 2016 Mar; 127(1):43-52. PubMed ID: 26615563
[TBL] [Abstract][Full Text] [Related]
37. Expression profiling of ependymomas unravels localization and tumor grade-specific tumorigenesis.
Palm T; Figarella-Branger D; Chapon F; Lacroix C; Gray F; Scaravilli F; Ellison DW; Salmon I; Vikkula M; Godfraind C
Cancer; 2009 Sep; 115(17):3955-68. PubMed ID: 19536879
[TBL] [Abstract][Full Text] [Related]
38. Supratentorial extraventricular ependymal neoplasms: a clinicopathologic study of 32 patients.
Shuangshoti S; Rushing EJ; Mena H; Olsen C; Sandberg GD
Cancer; 2005 Jun; 103(12):2598-605. PubMed ID: 15861411
[TBL] [Abstract][Full Text] [Related]
39. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
[TBL] [Abstract][Full Text] [Related]
40. Ependymomas of childhood. I. Histological survey and clinicopathological correlation.
Liu HM; Boogs J; Kidd J
Childs Brain; 1976; 2(2):92-110. PubMed ID: 971635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]